The reasons for unusable lipemic blood plasma in transfusion treatment
Introduction/Objective. The increased presence of lipid particles in blood is one of most common reasons that transfusion units are unusable. The risk factors for lipemic plasma in donated blood are not completely known. The aim of this study is to identify the factors that influence plasma to be fa...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Serbian Medical Society
2021-01-01
|
Series: | Srpski Arhiv za Celokupno Lekarstvo |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0370-8179/2021/0370-81792100040R.pdf |
id |
doaj-57ca5e37ebf440788d54a9e18ee7a9a1 |
---|---|
record_format |
Article |
spelling |
doaj-57ca5e37ebf440788d54a9e18ee7a9a12021-09-06T09:55:17ZengSerbian Medical SocietySrpski Arhiv za Celokupno Lekarstvo0370-81792406-08952021-01-011497-844945410.2298/SARH200919040R0370-81792100040RThe reasons for unusable lipemic blood plasma in transfusion treatmentRadonjić Dragan0Raičević Saša1Kljakić Duško2Varjačić Mirjana3https://orcid.org/0000-0003-1528-9305Blood Transfusion Institute of Montenegro, Bar Organizational Unit, Bar, MontenegroUniversity of Montenegro, Faculty of Medicine, Department of Gynecology and Obstetrics, Podgorica, Montenegro + Clinical Center of Montenegro, Podgorica, MontenegroBar General Hospital, Department of Gynaecology and Obstetrics, Bar, MontenegroUniversity of Kragujevac, Faculty of Medical Sciences, Department of Gynecology and Obstetrics, Kragujevac, SerbiaIntroduction/Objective. The increased presence of lipid particles in blood is one of most common reasons that transfusion units are unusable. The risk factors for lipemic plasma in donated blood are not completely known. The aim of this study is to identify the factors that influence plasma to be fatty so that we can prevent further storage costs and eliminate unusable transfusion units. Methods. This case–control study was conducted in 2017, and 1552 respondents were included in the study. The control group included 1502 subjects whose blood was not lipemic, while 50 patients with lipemic blood were selected for the case group. The presence of lipemic blood was assessed by inspection, while data were collected by clinical laboratory tests and a questionnaire. Results. Our findings show that multiple blood donors with lipemic blood were significantly older (p < 0.0005) and have higher systolic and diastolic pressure (p < 0.0005), high triglyceride levels (p < 0.0005), and lower levels of hemoglobin (p < 0.0005). Additionally, the presence of lipemic plasma was associated with female sex (p = 0.002), blood type (p = 0.016), heart disease (p < 0.0005), smoking (p < 0.005), diabetes (p = 0.001), lipid intake prior to blood donation (p < 0.005) and venipuncture therapy (p < 0.0005). Systolic pressure is a reliable predictor of lipemic blood (AUROC = 0.901, p < 0.0005). Conclusion. Our study provided a rational explanation and identified some of the risk factors that may help identify potential donors with lipemic blood.http://www.doiserbia.nb.rs/img/doi/0370-8179/2021/0370-81792100040R.pdfblood transfusionblood donorsplasmapreventive measurescholesteroltriglyceride |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Radonjić Dragan Raičević Saša Kljakić Duško Varjačić Mirjana |
spellingShingle |
Radonjić Dragan Raičević Saša Kljakić Duško Varjačić Mirjana The reasons for unusable lipemic blood plasma in transfusion treatment Srpski Arhiv za Celokupno Lekarstvo blood transfusion blood donors plasma preventive measures cholesterol triglyceride |
author_facet |
Radonjić Dragan Raičević Saša Kljakić Duško Varjačić Mirjana |
author_sort |
Radonjić Dragan |
title |
The reasons for unusable lipemic blood plasma in transfusion treatment |
title_short |
The reasons for unusable lipemic blood plasma in transfusion treatment |
title_full |
The reasons for unusable lipemic blood plasma in transfusion treatment |
title_fullStr |
The reasons for unusable lipemic blood plasma in transfusion treatment |
title_full_unstemmed |
The reasons for unusable lipemic blood plasma in transfusion treatment |
title_sort |
reasons for unusable lipemic blood plasma in transfusion treatment |
publisher |
Serbian Medical Society |
series |
Srpski Arhiv za Celokupno Lekarstvo |
issn |
0370-8179 2406-0895 |
publishDate |
2021-01-01 |
description |
Introduction/Objective. The increased presence of lipid particles in blood is one of most common reasons that transfusion units are unusable. The risk factors for lipemic plasma in donated blood are not completely known. The aim of this study is to identify the factors that influence plasma to be fatty so that we can prevent further storage costs and eliminate unusable transfusion units. Methods. This case–control study was conducted in 2017, and 1552 respondents were included in the study. The control group included 1502 subjects whose blood was not lipemic, while 50 patients with lipemic blood were selected for the case group. The presence of lipemic blood was assessed by inspection, while data were collected by clinical laboratory tests and a questionnaire. Results. Our findings show that multiple blood donors with lipemic blood were significantly older (p < 0.0005) and have higher systolic and diastolic pressure (p < 0.0005), high triglyceride levels (p < 0.0005), and lower levels of hemoglobin (p < 0.0005). Additionally, the presence of lipemic plasma was associated with female sex (p = 0.002), blood type (p = 0.016), heart disease (p < 0.0005), smoking (p < 0.005), diabetes (p = 0.001), lipid intake prior to blood donation (p < 0.005) and venipuncture therapy (p < 0.0005). Systolic pressure is a reliable predictor of lipemic blood (AUROC = 0.901, p < 0.0005). Conclusion. Our study provided a rational explanation and identified some of the risk factors that may help identify potential donors with lipemic blood. |
topic |
blood transfusion blood donors plasma preventive measures cholesterol triglyceride |
url |
http://www.doiserbia.nb.rs/img/doi/0370-8179/2021/0370-81792100040R.pdf |
work_keys_str_mv |
AT radonjicdragan thereasonsforunusablelipemicbloodplasmaintransfusiontreatment AT raicevicsasa thereasonsforunusablelipemicbloodplasmaintransfusiontreatment AT kljakicdusko thereasonsforunusablelipemicbloodplasmaintransfusiontreatment AT varjacicmirjana thereasonsforunusablelipemicbloodplasmaintransfusiontreatment AT radonjicdragan reasonsforunusablelipemicbloodplasmaintransfusiontreatment AT raicevicsasa reasonsforunusablelipemicbloodplasmaintransfusiontreatment AT kljakicdusko reasonsforunusablelipemicbloodplasmaintransfusiontreatment AT varjacicmirjana reasonsforunusablelipemicbloodplasmaintransfusiontreatment |
_version_ |
1717779714409496576 |